Unreferenced date March 2007 Vaccineefficacy is defined as the reduction in the incidence of a disease among people who have received a vaccine compared to the incidence in unvaccinated people. The efficacy of a new vaccine is measured in phase II or phase III clinical trial s by giving one group of people a vaccine and comparing the incidence of disease in that group to another group of people who do not receive the vaccine. . The basic formula is written as VE ARU ARV ARU x 100 where VE vaccineefficacy ARU attack rate in the unvaccinated population and ARV attack rate in the vaccinated population. Category Vaccination Infectious disease stub ... more details
of technical term Vaccineefficacy Efficiency disambiguation Figure of merit Self efficacy Effectiveness Political efficacy Potent References citations missing date May 2009 Reflist 2 Category ...refimprove date December 2010 Efficacy is the capacity to produce an effect. It has different specific meanings in different fields. Context Healthcare In a healthcare context, efficacy indicates the capacity for beneficial change or therapeutic effect of a given intervention e.g. a medicine , medical device , surgical procedure , or a public health intervention . If efficacy is established, an intervention is likely to be at least as good as other available interventions, to which it will have been compared. Comparisons of this type are typically made in explanatory randomized controlled trial s, whereas pragmatic trials are used to establish the effectiveness of an intervention. The concept of self efficacy is an important one in the self management of chronic medicine chronic diseases because doctors and patients often do not follow best practice in using a treatment. For instance, a patient ... in relation to an Individual Voluntary Arrangement, the efficacy of such an arrangement is judged .... Pharmacology main Intrinsic activity In pharmacology, efficacy, refers to the maximum response ... the efficacy relative to a drug which has the highest observed efficacy. Effectiveness refers ... which are typically biased compared with method effectiveness. Lighting Main Luminous efficacy In lighting design, efficacy refers to the amount of light luminous flux produced by a lamp a light ... from a heat source are typically less than two percent. Lutheranism In Lutheranism efficacy is used to describe the characteristics of Sola Scriptura Characteristics in Lutheranism Scripture . The efficacy ... and that this teaching produces faith and Lutheranism Good works obedience . Efficacy further means ... , par. 41 ref Difference amplifiers The efficacy of a differential amplifier is measured by the degree ... more details
efficacyefficacy or performance of the vaccine is dependent on a number of factors the disease itself ...Other uses bots deny Citation bot A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease causing microorganism ... are also being investigated see cancer vaccine . The term vaccine derives from Edward Jenner s 1796 ... Further experimentation demonstrated the efficacy of the procedure on an infant. ref name Dunn Since ... vaccine in England in the eighteenth and nineteenth centuries journal BMJ issue 5342 pages 1367 72 year ... generalized Jenner s idea by developing what he called a rabies vaccine, and in the nineteenth century ... of the polio vaccine in the 1950s and the Smallpox Eradication eradication of smallpox ... Stern Markel Types File ReverseGeneticsFlu.svg thumbnail 300px Avian influenza Avian flu vaccine development ... destroyed with chemicals or heat. Examples are the influenza vaccine , cholera vaccine , bubonic plague vaccine , polio vaccine , hepatitis A vaccine , and rabies vaccine . Attenuated Some vaccines contain ... typhoid . The live Mycobacterium tuberculosis vaccine developed by Calmette and Gu rin is not made of a Infectious ... Calmette Gu rin BCG used to elicit an immune response to the vaccine. The live attenuated vaccine containing ... of toxoid based vaccines include tetanus and diphtheria . Toxoid vaccines are known for their efficacy ... or attenuated micro organism to an immune system which would constitute a whole agent vaccine , a fragment of it can create an immune response. Examples include the subunit vaccine against Hepatitis B ... genes into yeast , the virus like particle VLP vaccine against human papillomavirus HPV that is composed ... virus. Subunit vaccine is being used for plague immunization. Conjugate Conjugate vaccine ... as if it were a protein antigen. This approach is used in the Haemophilus influenzae type B vaccine ... that have complex infection processes DNA vaccination in recent years a new type of vaccine called ... more details
Unreferenced date February 2008 Expert verify date February 2008 Political efficacy is a theoretical concept used to explain political behaviour in Political Science . It indicates citizen s faith and trust in government and his her own belief that he she can understand and influence Politics political affairs . It is commonly measured by Statistical survey survey s and used as an indicator for the broader health of civil society . Feelings of efficacy are highly correlation correlated with participation in social and political life however, studies have not shown any relationship between public confidence in government or political leaders and voting . Efficacy usually increases with age and education level. There are two types of political efficacy internal efficacy the belief that one can understand politics and therefore participate in politics and external efficacy the belief that one is effective when participating in politics, for example that the government will respond to one s demands . Category Political terms Efficacy Gov stub ... more details
Self efficacy is a term used in psychology , roughly corresponding to a person s belief in their own ... that create a meaning for individuals. It is believed that our personalized ideas of self efficacy ... of self efficacy is a vitally important goal for positive psychology because it can lead to living a more ... Bandura has defined self efficacy as one s belief in one s ability to succeed in specific situations. One s sense of self efficacy can play a major role in how one approaches goals, tasks, and challenges .... ref The concept of self efficacy lies at the center of Bandura s social cognitive theory , which ... stages of development. Since Self efficacy is developed from external experiences and self perception ... cognitive theory. Self efficacy represents the personal perception of external social factors. ref name Bandura, A. 1977 Bandura, A. , http psycnet.apa.org journals rev 84 2 191 Self efficacy Toward ... self efficacy that is, those who believe they can perform well are more likely to view difficult tasks ... such concepts as observational learning, imitation, and modeling. Self efficacy levels reflect ... or external situational to the person Influential to feelings of self esteem and self efficacy If success or failure is attributed to internal factors, success will lead to pride and increased self efficacy, whereas failure will diminish self esteem and negatively affect self efficacy 2. Stability whether ... self efficacy Failing at a task we cannot control can lead to shame or anger ref Heider, Fritz. 1958 . The Psychology of Interpersonal Relations. New York John Wiley & Sons ref How self efficacy ... if they believe they can succeed. People generally avoid tasks where their self efficacy is low, but will engage in tasks where their self efficacy is high. People with a self efficacy significantly .... On the other hand, people with a self efficacy significantly lower than their ability are unlikely to grow and expand their skills. Research shows that the optimum level of self efficacy ... more details
Luminous efficacy is a figure of merit for light source s. It is the ratio of luminous flux to power ... unclear. The former sense is sometimes called luminous efficacy of radiation , and the latter luminous efficacy of a source . The luminous efficacy of a source is a measure of the efficiency with which ... 9780849317934 page 123 url http books.google.com books?id XiOeYrhyVlEC&pg PA123&dq 22luminous efficacy ... v onepage&q 22luminous 20efficacy 20of 20a 20source 22&f false ref The luminous efficacy of radiation ...&pg PA338&dq luminous efficacy of radiation&hl en&ei 1QbLTOuwJ4mmsQPmis2JDw&sa X&oi book result&ct ... is useless for illumination. The overall luminous efficacy of a source is the product of how ... by the human eye. Efficacy and efficiency In some Units of measurement systems of units , luminous flux has the same units as radiant flux. The luminous efficacy of radiation is then dimensionless ... be expressed as a percentage. A common choice is to choose units such that the maximum possible efficacy, 683 lm W, corresponds to an efficiency of 100 . The distinction between efficacy and efficiency ... expressed in lumens per watt, or efficacies expressed as a percentage. Luminous efficacy of radiation ... are generally assumed. Luminous efficacy of radiation measures the fraction of electromagnetic power ... with wavelengths outside the visible spectrum reduces luminous efficacy, because it contributes ... s response contribute more strongly than those near the edges. In SI , luminous efficacy has units of Lumen unit lumen s per watt lm W . Photopic luminous efficacy of radiation has a maximum possible ... . Scotopic luminous efficacy of radiation reaches a maximum of 1700 lm W for narrowband light ... 300px class wikitable Type br Luminous efficacy of radiation br lm W Luminous efficiency ref ... sources are usually evaluated in terms of luminous efficacy of a source, also sometimes called overall luminous efficacy . This is the ratio between the total luminous flux emitted by a device and the total ... more details
File School Lunch Programs.gif thumb 250px A child praying before lunch, 1936 Determining the efficacy ... 24, 2006 ref To date, scientific and religious views on the efficacy of prayer do not agree, and much ... groups have objected to the very measurement of the efficacy of prayer and believe that what .... If and when more studies of prayer are done, the issue of prayer s efficacy may be further ... Washingtom Post ref Studies on the efficacy of prayer A number of studies have been performed to scientifically ... . There are, of course, also certain types of prayer whose efficacy can not by definition be measured ... One condition that may affect the efficacy of intercessory prayer is whether the person praying ... name galton Francis Galton, http www.abelard.org galton galton.htm Statistical Inquiries into the Efficacy ... the efficacy of prayer are involved in such courses. Different approaches to medicine In his book ... commented that most lay perceptions of the efficacy of prayer personal impressions as opposed to empirical ... the efficacy of prayer in the face of what he called the immutability of the laws of nature . He said ref William Bourn Oliver Peabody, Efficacy of prayer , in Sermons B.H. Greene Press, Boston, 1849 ... hold in an undoubting faith the doctrine of the efficacy of our prayers, or to use the language ... . blockquote Peabody then argued at length that prayers may have efficacy in a form that does not interfere ... he wrote ref George Burnap, The efficacy of prayer in Christianity, its essence and evidence Crosby ... accepted by the Lourdes Medical Bureau . Massive prayer The scientific measurement of the efficacy ... s efficacy exist. Some interpret Deuteronomy 6 16 You shall not put the Lord your God to the test ref ... also wrote For although I had long ceased to believe in the efficacy of prayer, I was so lonely and so ... ceased to believe in their efficacy. ref Bertrand Russell, The Collected Papers of Bertrand Russell ... teachings Christian authors have contended for long that the efficacy of prayer involves the action ... more details
A vaccine trial is a clinical trial that aims at establishing the safety and vaccineefficacyefficacy of a vaccine prior to it being licensed. ref cite book first1 M. Elizabeth last1 Halloran first2 Ira M., Jr. last2 Longini first3 Claudio J. last3 Struchiner title Design and analysis of vaccine studies publisher Springer series Statistics for biology and health location New York year 2010 pages xviii 387 isbn 978 0 387 40313 7 id MR 2572061 ref Methodology A vaccine trial might involve forming two groups from the target population. For example, from the set of trail subjects, each subject may be randomly assigned to receive either a new vaccine or a control group control treatment The control treatment may be a placebo controlled studies placebo , or an adjuvant containing cocktail, or an established vaccine which might be intended to protect against a different pathogen . After the administration of the vaccine or placebo, the researchers collect data on antibody production, on health outcomes such as illness due to the targeted infection or to another infection . This data is summarized as a statistic , which is used to estimate the protective efficacy of the vaccine. Then, following the protocol natural sciences trial protocol , the specified Statistical hypothesis testing statistical ... between the treatment and control groups. Adverse effect medicine Side effects of the vaccine ... issues and problems Vaccine trials may take months or years to complete, since a sufficient time period must elapse for the subjects to react to the vaccine and develop the required Antibody antibodies ... first3 Claudio J. last3 Struchiner title Design and analysis of vaccine studies publisher Springer ... 0 387 40313 7 id MR 2572061 Vaccines Medical research studies External links http www.vrc.nih.gov Vaccine Research Center Information regarding preventative vaccine research studies Category Virology Category Microbiology Category Immunology Category Vaccination Trial, Vaccine Category Clinical research ... more details
Drugbox verifiedrevid 406373970 type vaccine image target Yersinia pestis vaccine type live CAS number ATC prefix J07 ATC suffix AK01 PubChem DrugBank pregnancy AU A B1 B2 B3 C D X pregnancy US A B C D X pregnancy category legal AU S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled legal CA Schedule I, II, III, IV, V, VI, VII, VIII legal UK GSL, P, POM, CD, or Class A, B, C legal US OTC Rx only Schedule I, II, III, IV, V legal status routes of administration Plague vaccine is a vaccine used against Yersinia pestis . ref name pmid17652523 cite journal author Bubeck SS, Dube PH title Yersinia pestis CO92 delta yopH is a potent live, attenuated plague vaccine journal Clin. Vaccine Immunol. volume 14 issue 9 pages 1235 8 year 2007 month September pmid 17652523 pmc 2043315 doi 10.1128 CVI.00137 07 url http cvi.asm.org cgi pmidlookup?view long&pmid 17652523 ref ref MeshName Plague Vaccine ref Plague immunization Main Plague immunization A plague vaccine is used for an induction of active specific immunity medical immunity in a susceptible organism to plague disease by means of administration an antigen ic material a vaccine via a variety of routes to people at risk of contracting any clinical form of plague disease . This metod is known as plague immunization . There is strong evidence for the efficacy of administration of some plague vaccines in preventing or ameliorating the effects of a variety of clinical forms of infection by Yersinia pestis . Plague immunization also encompasses incurring state of passive specific immunity medical immunity to plague disease in a susceptible organism after administration of a plague serum or plague immunoglobulin in people with an immediate risk of developing the disease. ref http www.who.int vaccine research diseases zoonotic en index5.html ref References reflist Vaccines Category Vaccines infectious disease stub immunology stub ... more details
Drugbox verifiedrevid 403971681 type vaccine image target Haemophilus influenzae type b vaccine type ... of administration Haemophilus influenzae type B vaccine Hib janan or PRP vaccine ref cite journal title Haemophilus influenzae Type b Conjugate Vaccine Meningicoccal Protein Conjugate Immunogenicity ... 85 issue 4 pages 690 693 pmid 2107520 ref is a conjugate vaccine developed for the prevention of invasive ... CDC has recommended the use of the Hib vaccine. ref cite journal title Recommendation of the Immunization Practices Advisory Committee ACIP Polysaccharide Vaccine for Prevention of Haemophilus ... pages 201 5 issn 0149 2195 ref Due to routine use of the Hib vaccine in the United States U.S. from ... publisher GAVI Alliance ref History and vaccine composition Polysaccharide vaccine The first Hib vaccine licensed was a pure polysaccharide vaccine, first marketed in the US in 1985. ref name Pink Book cite book title Epidemiology and Prevention of Vaccine Preventable Diseases author Centers for Disease ... vaccines, immune response to the vaccine was highly age dependent. Children under 18 months of age did not produce a positive response for this vaccine. As a result, the age group with the highest incidence of Hib disease was unprotected, limiting the usefulness of the vaccine. The vaccine was withdrawn from the market in 1988. Conjugate vaccine The shortcomings of the polysaccharide vaccine lead to the production of the Hib polysaccharide protein conjugate vaccine. ref name Pink Book Attaching ... three types of conjugate vaccine utilizing different proteins in the conjugation process, all of which ... protein. Combination vaccines Multiple combination vaccine combination s of Hib and other vaccines .... Hib vaccine combined with DPT vaccine diphtheria tetanus pertussis polio vaccine s and Hepatitis B vaccine s are available in the US. The World Health Organization WHO has certified several Hib vaccine ... all manifestations of Hib disease, with a clinical efficacy among fully vaccinated children estimated ... more details
Drugbox type vaccine image target Bordetella pertussis vaccine type varies CAS number ATC prefix J07 ATC suffix AJ01 ATC supplemental ATC J07 AJ02 PubChem DrugBank pregnancy AU A B1 B2 B3 C D X pregnancy US A B C D X pregnancy category legal AU S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled legal CA Schedule I, II, III, IV, V, VI, VII, VIII legal UK GSL, P, POM, CD, or Class A, B, C legal US OTC Rx only Schedule I, II, III, IV, V legal status routes of administration Pertussis vaccine is a vaccine used against Bordetella pertussis . ref name urlMedlinePlus Medical Encyclopedia Pertussis vaccine cite web url http www.nlm.nih.gov medlineplus ency article 001561.htm title MedlinePlus Medical Encyclopedia Pertussis work accessdate 2010 07 02 ref It is a component of the DPT vaccine . Older versions of the vaccine involved inactivated cells. Newer versions are acellular, and are less likely to provoke a febrile state. ref cite journal author Patel SS, Wagstaff AJ title Acellular pertussis vaccine Infanrix DTPa SB 3 . A review of its immunogenicity, protective efficacy and tolerability in the prevention of Bordetella pertussis infection journal Drugs volume 52 month Aug pages 254 275 year 1996 pmid 8841742 issue 2 ref References Reflist Vaccines vaccine stub Category Vaccines ... more details
innate immune responses impact upon efficacy and toxicity in gene therapy and vaccine applications ...An adenovirus vaccine is a vaccine against Adenovirus . ref name pmid18251691 cite journal author Tucker SN, Tingley DW, Scallan CD title Oral adenoviral based vaccines historical perspective and future opportunity journal Expert Rev Vaccines volume 7 issue 1 pages 25 31 year 2008 month February pmid 18251691 doi 10.1586 14760584.7.1.25 url http www.future drugs.com doi abs 10.1586 14760584.7.1.25?url ver Z39.88 2003&rfr id ori rid crossref.org&rfr dat cr pub 3dncbi.nlm.nih.gov ref It was used by the United States military from 1971 to 1999, but was discontinued when the only manufacturer stopped production. ref name pmid16480793 cite journal author Russell KL, Hawksworth AW, Ryan MA, et al. title Vaccine preventable adenoviral respiratory illness in US military recruits, 1999 2004 journal Vaccine volume 24 issue 15 pages 2835 42 year 2006 month April pmid 16480793 pmc 1955759 doi 10.1016 j.vaccine.2005.12.062 url http linkinghub.elsevier.com retrieve pii S0264 410X 06 00016 8 ref ref name urlVaccine Trials For Boot Camp Crud May Help 20 Percent of Recruits cite web url http www.navy.mil search display.asp?story id 26369 title Vaccine Trials For Boot Camp Crud May Help 20 Percent of Recruits format work accessdate 2009 01 15 ref This virus was against serotypes 4 and 7. ref name pmid11456329 cite journal author title Two fatal cases of adenovirus related illness in previously healthy ... ref On March 16, 2011, the U.S. Food and Drug Administration approved an adenovirus vaccine manufactured ... letter dated March 16, 2011. ref This vaccine is essentially the same as the one used from 1971 ... journal author Croyle MA, Patel A, Tran KN, et al. title Nasal delivery of an adenovirus based vaccine bypasses pre existing immunity to the vaccine carrier and improves the immune response in mice journal ... pmid15451446 cite journal author Tatsis N, Ertl HC title Adenoviruses as vaccine vectors journal ... more details
Introduction While self efficacy , in general, refers to one s confidence in executing courses of action in managing a wide array of situations, work self efficacy assesses workers confidence in managing ... with higher work self efficacy are more likely to look forward to, and to be successful ... self efficacy through a feedback loop tying subsequent performance to augmented self efficacy beliefs. Background to the Construct of Work Self Efficacy Self efficacy has been widely established in the literature ... efficacy. Advances in Behavioral Research and Therapy , 1 4 , 237 269. ref social learning theory ... efficacy expectations are considered the primary cognitive determinant of whether or not an individual will attempt a given behavior. Self efficacy is known to have considerable potential explanatory ..., coping, choice of career opportunities, and career competency. ref Bandura, A. 1982 . Self efficacy .... 1987 . Career Self Efficacy Empirical Status and Future Directions. Journal of Vocational Behavior ... performance. ref Gist, M.E., & Mitchell, T.R. 1992 . Self efficacy A theoretical analysis of its ...., & Luthans, F. 1998 . Self efficacy and work related performance A meta analysis. Psychological Bulletin , 124, 240 261. ref Most efforts to measure self efficacy have focused on a subject s expectations ... efficacy beliefs. However, researchers such as Sherer et al. ref Scherer, M., Maddux, J. E., Mercandante, B., Prentice Dunn, S., Jacobs, B., & Rogers, R.W. 1982 . The self efficacy scale Construction ..., S. M., & Eden, D. 2001 . Validation of a new general self efficacy scale. Organizational Research ... a history of varied and numerous experiences of success can be expected to have positive self efficacy ... self efficacy, though a possible predictor, general self efficacy is thought to be a motivational state, whereas task specific self efficacy a motivational trait. ref Eden, D. 1988 . Pygmalion ..., 639 652. ref ref Gardner, D.G., & Pierce, J.L. 1998 . Self esteem and self efficacy within the organizational ... more details
11447162 issue 8 pmc 98576 ref It is believed that this improves vaccineefficacy and also avoids ...A pneumococcal vaccine is a vaccine against Streptococcus pneumoniae . ref MeshName Pneumococcal Vaccines ref Types include Pneumococcal polysaccharide vaccine Pneumococcal conjugate vaccine Vaccination in the USA In the USA, a heptavalent pneumococcal conjugate vaccinevaccine PCV 7 e.g. Prevenar ref ... to a serotype of pneumococcus that is not contained in the vaccine, he she is not afforded ... wide protection. Pneumococcal polysaccharide vaccine Pneumovax is one brand gives at least 85 protection ... at highest risk of infection, including those 65 years or older generally the vaccine should be a single ... that the UK government would introduce vaccination with the conjugate vaccine in children aged 2, 4 ... vaccine BBC News , February 8, 2006, retrieved August 25, 2006 ref ref name DoHPress http www.dh.gov.uk ... Pneumococcal vaccine added to the childhood immunisation programme February 8, 2006 ref This is expected ... conjugate vaccine for use in Europe. ref Synflorix, GlaxoSmithKline s pneumococcal vaccine receives ... . The 13 valent pneumococcal vaccine has been introduced in the routine immunisation schedule of the UK ... PneumoADIP website http www.pneumoadip.com PneumoADIP website ref Vaccine research Due to the geographic ... vaccine for developing world populations. In a previous study, the most common pneumococcal serotypes ... pneumococcal isolates from children implications for vaccine strategies. Pediatric Infectious Disease Journal . 1995 14 6 503 510. ref In order to further pneumococcal vaccine research and reduce childhood ... title Mucosal delivery of a Pneumococcal vaccine using Lactococcus lactis affords protection against ... scholar.google.co.uk scholar?hl en&lr &q intitle 3AMucosal delivery of a Pneumococcal vaccine using ... and Inflammation in a Mouse Model of Systemic Pneumococcal Infection journal Clin Vaccine Immunol ... Additional pneumococcal vaccine research is taking place to find a vaccine that offers broad protection ... more details
vaccine published in 2009 indicated an efficacy of 50 , thus the protection provided was limited ...A Cytomegalovirus vaccine is a vaccine against cytomegalovirus CMV such a vaccine is currently under investigation. ref name pmid17547509 cite journal author Zhong J, Khanna R title Vaccine strategies against human cytomegalovirus infection journal Expert Rev Anti Infect Ther volume 5 issue 3 pages 449 59 year 2007 month June pmid 17547509 doi 10.1586 14787210.5.3.449 url http www.future drugs.com doi abs 10.1586 14787210.5.3.449?url ver Z39.88 2003&rfr id ori rid crossref.org&rfr dat cr pub 3dncbi.nlm.nih.gov ref ref name pmid18806877 cite journal author Zhong J, Rist M, Cooper L, Smith C, Khanna R title Induction of pluripotent protective immunity following immunisation with a chimeric vaccine against human cytomegalovirus journal PLoS ONE volume 3 issue 9 pages e3256 year 2008 pmid 18806877 pmc 2533118 doi 10.1371 journal.pone.0003256 url http www.plosone.org article info doi 10.1371 journal.pone.0003256 ref As a member of the TORCH complex , cytomegalovirus can cause congenital infection. Because of this, there has been considerable effort made towards the development of a vaccine ... Schleiss MR title Comparison of vaccine strategies against congenital CMV infection in the guinea ..., members of this population are less likely to be candidates for such a vaccine. Development of such a vaccine has been emphasized as a priority by the National Vaccine Program Office in the United ... vaccine time to look for alternative options journal Trends Mol Med volume 12 issue 1 pages 26 33 ... P, Myers M, Plotkin S, Rabinovich R title Vaccine development to prevent cytomegalovirus disease report from the National Vaccine Advisory Committee journal Clin. Infect. Dis. volume 39 issue 2 pages ... cytomegalovirus dense body vaccine journal Med. Microbiol. Immunol. volume 197 issue 2 pages ... CMV was encountered. ref cite journal author Pass RF, Zhang C, Evans A, et al title Vaccine prevention ... more details
when considering potential vaccine candidates. The development of resistance could cause a significant reduction in efficacy of any potential vaccine thus rendering useless a carefully developed ... to attempt to increase the efficacy of the vaccine further, therefore acting synergistically with the adjuvant ... beneficial when examining the potential efficacy of a vaccine candidate and is hoped to enable .... The vaccineefficacy was reported at approximately 71 with 95 confidence intervals spanning ... against inoculated individuals, therefore as the efficacy of the vaccine decreased it was being tested ..., Lusingu J, Olotu A, et al. title Efficacy of RTS,S AS01E vaccine against malaria in children 5 to 17 ... of intensive research, however, there is no effective vaccine that has been introduced into clinical practice. There is one candidate vaccine, known as RTS,S AS01, which started Pivotal Phase ... vaccine will be needed to facilitate eradication. There has been a great increase in funding for such research ... no effective vaccine for malaria has so far been developed. Despite this, researchers remain hopeful ... the RTS,S AS01 malaria vaccine candidate. Citation needed date December 2008 Considerations for vaccine development The task of developing a preventative vaccine for malaria is a complex process. There are a number of considerations to be made concerning what strategy a potential vaccine should ... immunity and a cell mediated immune response. Ideally a vaccine would enable the development ... antigens against which a vaccine could be targeted will be discussed in greater depth later. Antibodies ... vaccine could target the production of TNF a, preventing respiratory distress and cerebral symptoms ... reduces the associated pathology. As a result, there are substantial difficulties in evaluating efficacy in human trials. Taking this information into consideration an ideal vaccine candidate would attempt ... of a vaccine By their very nature, parasites are more complex organisms than bacteria and viruses ... more details
Drug Efficacy Study Implementation DESI was a program begun by the Food and Drug Administration FDA in the 1960s after the requirement in the Kefauver Harris Amendment Kefauver Harris Drug Control Act that all drug s be efficacious as well as safe. The DESI program was intended to classify all pre 1962 drugs that were already on the market as either effective, ineffective, or needing further study. The Drug Efficacy Study Implementation DESI evaluated over 3000 separate products and over 16,000 therapeutic claims. By 1984, final action had been completed on 3,443 products of these, 2,225 were found to be effective, 1,051 were found not effective, and 167 were pending. One of the early effects of the DESI study was the development of the Abbreviated New Drug Application ANDA . See also Regulation of therapeutic goods Federal Food, Drug, and Cosmetic Act Estes Kefauver References USDHHS PD http www7.nationalacademies.org archives drugefficacy.html The Drug Efficacy Study of the National Research Council s Division of Medical Sciences The Annals of Pharmacotherapy Vol. 39, No. 7, pp. 1260 1264. DOI 10.1345 aph.1E569 http www.theannals.com cgi content abstract 39 7 1260 Category clinical research Category Pharmaceuticals policy Category United States Department of Health and Human Services US gov stub es Drug Efficacy Study Implementation ... more details
Drugbox verifiedrevid 413264937 type vaccine image target Rabies vaccine type killed CAS number ATC prefix ..., III, IV, V legal status routes of administration Rabies vaccine is a vaccine used to control rabies ... rabies vaccine containing the Pasteur strain of killed rabies virus. Several different ... and Emile Roux developed the first rabies vaccination in 1885 . This vaccine was first used on a human ... Their vaccine consisted of a sample of the virus harvested from infected and necessarily dead rabbits ..., they are not as effective. Citation needed date January 2009 Neural tissue vaccine also carry a certain ... vaccine journal Neurol India volume 52 issue 1 pages 132 3 year 2004 month March pmid 15069272 doi url ... 133 aulast Srivastava ref Modern vaccines The human diploid cell rabies vaccine H.D.C.V. was started ... 2010 04 23. ref developed and produced a dog vaccine that gave a three year immunity from rabies . The development of the vaccine resulted in the elimination of rabies in many parts of the Visayas ... embryo cell vaccine, and purified Vero cell rabies vaccine are now available. The purified Vero cell rabies vaccine uses the attenuated Wistar strain of the rabies virus, and uses the Vero cell line as its host. Recombinant rabies vaccine V RG Image Rabies vaccine in bait.jpg thumb Aerially distributed wildlife rabies vaccine in a bait from Estonia. In 1984 researchers at the Wistar Institute developed a Recombinant DNA recombinant vaccine called V RG by inserting the glycoprotein gene from ... pmc 392104 ref The V RG vaccine has since been commercialised by Merial under the trademark ... and efficacy trials in Canadian wildlife journal Can. J. Vet. Res. volume 54 issue 4 pages 504 ... , Germany and the United States to prevent outbreaks of rabies in wildlife . The vaccine is stable ... vaccine was found to be between 2 to 3 years. ref http www.spmsd.co.uk file.asp?docid 140 Patient Group Direction Information for Rabies Vaccine BP Sanofi Pasteur MSD , page 3 ref ref http www.travelturtle.co.uk ... more details
and Tropical Medicine . ref name SabinSVI http sabin.org vaccine development vaccines schisto Schistosomiasis Overview , Sabin Vaccine Institute ref External links http clinicaltrials.gov ct2 show NCT00870649?term Schistosomiasis vaccine&rank 1 Efficacy of Vaccine Sh28GST in Association With Praziquantel ...A Schistosomiasis vaccine is a vaccine against Schistosomiasis also known as bilharzia , bilharziosis or snail fever , a parasitic disease caused by several species of Trematoda fluke of the genus Schistosoma . Schistosomiasis affects over 200 million people worldwide, mainly in rural agricultural and peri urban areas of developing countries , and approximately 10 suffer severe health complications from the infection. ref name McManus & Loukas While chemotherepeutic drugs, such as praziquantel , oxamniquine and metrifonate , are currently considered safe and effective for the treatment of schistosomiasis, reinfection occurs frequently following drug treatment, thus a vaccine is sought to provide long term treatment. ref name pmid18577363 cite journal author Oliveira SC, Fonseca CT, Cardoso FC, Farias LP, Leite LC title Recent advances in vaccine research against schistosomiasis in Brazil journal Acta Trop. volume 108 issue 2 3 pages 256 62 year 2008 pmid 18577363 doi 10.1016 j.actatropica.2008.05.023 url http linkinghub.elsevier.com retrieve pii S0001 706X 08 00169 1 ref ref name McManus ... as a vaccine candidate. ref name pmid18426875 cite journal author Jiz M, Wu HW, Meng R, et al. title Pilot scale production and characterization of paramyosin, a vaccine candidate for schistosomiasis ... to paramyosin, a vaccine candidate for schistosomiasis, and their correlations with resistance ... T, Maruyama H, Yoshida A, He Y, Zhang R title Research on calpain of Schistosoma japonicum as a vaccine ... The biotechnology value chain development of Sm14 as a schistosomiasis vaccine journal Acta Trop. volume ... come from the Schistosomiasis Vaccine Initiative, a program of the Sabin Vaccine Institute in collaboration ... more details
s efficacy . In contrast, in the field, the effectiveness of a vaccine is the practical reduction ... benefitted by the vaccine, with an average efficacy rate ranging from 40 50 at age 65, and only ...Merge from Fluzone discuss Talk Influenza vaccine Fluzone Merge discussion date February 2011 Flu Image Influenza virus.jpg frame Model of Influenza Virus from NIH The influenza vaccine , also known as flu shot , is an annual vaccine to protect against the highly variable influenza virus . ref cite journal last1 Couch first1 RB title Seasonal inactivated influenza virus vaccines. journal Vaccine volume ... Each injected seasonal influenza vaccine contains three influenza viruses one A H3N2 virus, one regular ... Influenza Flu Key Facts About Seasonal Flu Vaccine Bot generated title ref Purpose and benefits of annual ... news title A Multitude of Vaccine Benefits, Yet Controversy Persists quote Public health experts generally ... influenza related hospitalizations is many times the number of deaths. ref Huge flu vaccine trial ..., should be considered a high priority for the flu vaccine. ref name autogenerated1 U.S. panel recommends ..., Masatoki Satob, Peter F. Wright The effectiveness of trivalent inactivated influenza vaccine in children over six consecutive influenza seasons Vaccine Volume 29, Issue 9, 17 February 2011, Pages ... vaccines were recommended to pregnant women inactivated trivalent 2009 10 seasonal vaccine and influenza A H1N1 2009 monovalent vaccine 2,5 url http www.cdc.gov mmwr pdf wk mm5947.pdf ref and children ... as soon as the 2009 10 influenza vaccine is available. Annual vaccination of all children aged 6 ... having to be hospitalized with the flu. The effectiveness of influenza vaccine given to mothers ... K. D. last4 Shapiro first4 E. D. last5 V zquez first5 M. title Influenza vaccine given to pregnant ... adults who received influenza vaccine reported 25 percent fewer episodes of upper respiratory illness ... included an assessment of patient mortality relative to staff influenza vaccine. Both studies including ... more details
The term Vaccine may refer to Vaccine , a class of medication typically used in prevention of disease Vaccination , the process of administering a vaccineVaccine musician , aka Christine Clements, an electronic musician who works primarily within the dubstep genre Vaccine journal Vaccine journal , a medical journal Vaccine , a song by the band Mew band Mew from their 2009 album No More Stories... The Vaccines , UK band disambig ... more details
incidence of polio, and thus a different relative risk between efficacy and reversion of the vaccine ...Drugbox verifiedrevid 417855487 type vaccine image Poliodrops.jpg target Polio virus vaccine type killed ... care professional. routes of administration Parenteral IPV , Oral drops OPV Two polio vaccine s are used ... dose of inactivated dead poliovirus . An oral vaccine was developed by Albert Sabin using Attenuated virus attenuated poliovirus. Clinical trial Human trials of Sabin s vaccine began in 1957 and it was licensed ... vaccine viruses implications for the global poliomyelitis eradication initiative url http aje.oxfordjournals.org ... author title Update on vaccine derived polioviruses journal MMWR Morb. Mortal. Wkly. Rep. volume 55 ... journal author Kew O, Sutter R, de Gourville E, Dowdle W, Pallansch M title Vaccine derived polioviruses ... vaccine recipients and herd immunity the wider community . ref name Fine In 1936, Maurice Brodie ... vaccine from ground up monkey spinal cord s. His initial attempts were hampered by the difficulty of obtaining enough virus. Brodie first tested the vaccine on himself and several of his assistants. He then gave the vaccine to three thousand children, many of whom developed allergic reactions, but none ... 1738787 ref Philadelphia pathologist John Kolmer also claimed to have developed a vaccine that same ... cgi pmidlookup?view long&pmid 17794160 ref This development greatly facilitated vaccine research ..., millions of dollars were invested in finding and marketing a polio vaccine by commercial interests ... successful polio vaccine, in 1950. His vaccine, however, being a live attenuated virus taken orally ... s polio vaccine a dead injectable vaccine had reached the market. Koprowski s attenuated vaccine ..., the vaccine strains could no longer infect nervous tissue or cause paralysis. After one to three further passages on rats, the vaccine was deemed safe for human use. ref name Sanofi ref cite journal ..., Koprowski s live, attenuated vaccine was tested for the first time on an eight year old boy from ... more details
refimprove date September 2009 The Food and Drug Administration United States FDA Animal Efficacy Rule finalized May 2002 applies to development testing of drugs biologicals to reduce or prevent serious life threatening conditions caused by exposure to lethal permanently disabling toxic agent chemical, biological, radiological, or nuclear substances , where human efficacy trials are not feasible or ethical. FDA can rely on evidence from Animal testing animal studies to provide substantial evidence of product effectiveness when 1 There is a reasonably well understood mechanism for the toxicity of the agent and its amelioration or prevention by the product 2 The effect is demonstrated in either 2.1 More than one animal species expected to react with a response predictive for humans or 2.2 One well characterized animal species model adequately evaluated for its responsiveness in humans for predicting the response in humans. 3 The animal Clinical endpoint study endpoint is clearly related to the desired benefit in humans and 4 Data or information on the pharmaco kinetics and pharmaco dynamics of the product or other relevant data or information in animals or humans is sufficiently well understood to allow selection of an effective dose in humans, and it is therefore reasonable to expect the effectiveness of the product in animals to be a reliable indicator of its effectiveness in humans. References http www.fda.gov OHRMS DOCKETS 98fr 053102a.htm http www.hhs.gov nvpo policy reg.html http www.fda.gov Drugs GuidanceComplianceRegulatoryInformation Post marketingPhaseIVCommitments ucm070766.htm q14 Category Animal testing ... more details
, Elizaga M, Duerr A title HIV vaccineefficacy trials towards the future of HIV prevention journal ...Update date March 2011 An HIV vaccine that protects vaccination vaccinated individuals from HIV infection is the goal of many HIV research programmes. Currently, there is no effective vaccine against HIV, the virus that causes AIDS . Vaccine development is one of several strategies to reduce the worldwide ... campaigns. There is evidence that a vaccine may be possible. Work with monoclonal antibody monoclonal ... of the search for a vaccine against HIV stems from the AIDS related death toll of over 25 million ... AIDS epidemic, July 2004 ref Alternative medical treatments to a vaccine do exist. Highly active ... rates. Therefore, an HIV vaccine is generally considered as the most likely, and perhaps the only way ... a difficult target for a vaccine. Difficulties in developing an HIV vaccine In 1984, after the confirmation ... declared that a vaccine would be available within two years. ref Shilts, Randy 1987 . And the Band ... have failed in the case of HIV 1. Some have stated that an HIV vaccine may not be possible without significant ... Vaccine Development journal Top HIV Med volume 16 issue 1 pages 7 8 year 2008 pmid 18441377 doi url ... that cause development of an HIV vaccine to differ from the development of other classic vaccines ref A. S. Fauci, 1996, An HIV vaccine breaking the paradigms, Proc. Am. Assoc. Phys. 108 6. ref ... HIV 1 does not retain antigenicity and the use of a live retrovirus vaccine raises safety issues. Most ... divergence. Therefore, the immune responses raised by any vaccine need to be broad enough to account for this variability. Any vaccine that lacks this breadth is unlikely to be effective. The difficulties in stimulating a reliable antibody response has led to the attempts to develop a vaccine that stimulates ... 0891 5520 ref ref name pmid18425263 cite journal author Watkins DI title The hope for an HIV vaccine ... S, Im EJ, Mashishi T, et al. title Design and pre clinical evaluation of a universal HIV 1 vaccine ... more details
to test women who have received the vaccine to determine the vaccine s efficacy over a lifetime ...Drugbox verifiedrevid 414802389 type vaccine image Gardasil vaccine and box new.jpg target human papillomavirus vaccine type protein subunit CAS number ATC prefix J07 ATC suffix BM01 ATC supplemental ATC ... HPV species are named type 16, etc. Not a serotype. The human papilloma virus HPV vaccine may ... 13 ref Two HPV vaccine s are currently on the market Gardasil and Cervarix . ref http www.reuters.com ... New Report Examines Laws that Would Mandate HPV Vaccine for Young Women accessdate 2010 02 13 ref Worldwide .... ref http www.plannedparenthood.org issues action std hiv hpv vaccine reports HPV 6359.htm Planned ..., 2002 ref Since the vaccine only covers some high risk types of HPV, experts still recommend regular ... pmid 20508594 cite pmid 20508594 ref Efficacy Both Gardasil ref name National Cancer Institute HPV Q&A cite web url http www.cancer.gov cancertopics factsheet risk HPV vaccine title Human Papillomavirus ... International AIDS Vaccine Initiative accessdate 2006 08 28 month January year 2006 archiveurl ... P, Quint W, Dubin G, Jenkins D, et al. title Sustained immunogenicity and high efficacy against ... GSK s HPV 16 18 AS04 candidate vaccine . journal Gynecol Oncol year 2008 volume 109 pages 158 ... Effective for 5 Years publisher Vaccine Rx accessdate 2007 04 19 date April 18, 2007 archiveurl http ... 402&newsid 847 title New data show Cervarix, GSK S HPV 16 18 cervical cancer candidate vaccine ... first John url http www.imwr.com issues articles 2007 11 24.asp title HPV Vaccine Protects Against ... dose injection vaccine. As of 2009 9 1 there have been more than 26 million doses distributed in the United States, and there have been 15,037 Vaccine Adverse Event Reporting System VAERS reports following the vaccination. ref name CDC VAERS Vaccine Adverse Event Reporting System Ninety two percent ... the vaccine and serious adverse effects all reports are related by time only. That is, they are only ... more details
Encyclopedia
top
